The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

A.L. Kovalenko

STPF «POLYSAN»

J.Yu. Chefranova

Belgorod Regional Clinical Hospital of St. Joasaph

T.V. Kharitonova

STPF «POLYSAN»

N.A. Lycheva

STPF «POLYSAN»

V.A. Kondakova

STPF «POLYSAN»

Iu.A. Pfarger

STPF «POLYSAN»

O.S. Ketlinskaya

STPF «POLYSAN»

Results of a clinical and experimental study of the safety and efficacy of Cytoflavin in combination with reperfusion therapy for ischemic stroke

Authors:

A.L. Kovalenko, J.Yu. Chefranova, T.V. Kharitonova, N.A. Lycheva, V.A. Kondakova, Iu.A. Pfarger, O.S. Ketlinskaya

More about the authors

Views: 606

Downloaded: 1


To cite this article:

Kovalenko AL, Chefranova JYu, Kharitonova TV, Lycheva NA, Kondakova VA, Pfarger IuA, Ketlinskaya OS. Results of a clinical and experimental study of the safety and efficacy of Cytoflavin in combination with reperfusion therapy for ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(8):75‑81. (In Russ.)
https://doi.org/10.17116/jnevro202312308175

Recommended articles:
The successful use of Cyto­flavin in the patient with postaveny syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(7):108-111
Difficulties in diagnosing the chro­nic course of tick-borne ence­phalitis in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(10):118-122
Safety of caro­tid enda­rterectomy in patients over 70 years old in early period after ischemic stroke. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(1):82-88

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.